Beckman Coulter, Inc., Lonza, and Thermo Fisher Scientific Inc have Dominated the Global Automated Cell Cultures Market in 2021

Global Automated Cell Cultures Market is expected to grow with the CAGR of 8.8% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-automated-cell-cultures-market

Global automated cell cultures market is a highly fragmented market, which includes many key players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in global automated cell cultures market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement, business expansion, award and recognition into the market. This helped companies to maximize the sales with enhanced product portfolio.

For instance:

  • In August 2021, Lonza, a global manufacturing partner to the pharma, biotech, and nutrition industries, announced that it would invest in establishing drug product manufacturing capabilities at its site in Guangzhou, China. The investment will establish drug product manufacturing capacity for clinical trial and commercial supply in China and offer customers combined drug substance and drug product manufacturing services.

Beckman Coulter, Inc., is the dominating player in global automated cell cultures market. The other key players existing in the market are Sartorius AG,Danaher, Nexcelom Bioscience LLC., HiMedia Laboratories, Cell Culture Company, LLC, Advanced Instruments, SHIBUYA CORPORATION, NanoEntek America, Inc., FUJIFILM Holdings America Corporation, Hitachi, Ltd., Kawasaki Heavy Industries, ltd., Sphere Fluidics Limited, Thrive Bioscience, Inc., Eppendorf AG, CellGenix GmbH, Scientica Instrumentation, Inc., ChemoMetec,PromoCell GmbH, Thermo Fisher Scientific Inc., BioSpherix, Ltd., Merck KGaA, Tecan Trading AG, Hamilton Company, BD, Benchmark scientific, Inc., Biotron Healthcare, RWD Life Science Co., LTD, Corning Incorporated, Bulldog Bio., and Sphere Fluidics Limited, among others.

Automated Cell Cultures MarketBeckman Coulter, Inc.

Beckman Coulter, Inc. headquartered in California, U.S., founded in 1935. The company focuses on advancing and optimizing the laboratory. The product categories offered by the companies are instruments, reagents, supplies, parts & accessories, and software. The business segments of the company are Life Sciences, Environmental & Applied Solutions, and Diagnostic.

For instance,

  • In July 2020, Beckman Coulter, Inc. has received the scientists' choice award for best new clinical laboratory instrumentation of 2019 for its DxA 5000 total laboratory automation system. This award has helped the company to attract a more customer base.

The company has wide presence across North America, South America, Europe, Asia-Pacific, Middle East and Africa. The company also has various subsidiary companies such as Beckman Coulter Korea Ltd. (Korea), Labcyte Inc. (U.S.), Beckman Coulter Hong Kong Ltd. (China), Beckman Coulter Gmbh (Germany), and Beckman Coulter Australia Pty. Ltd. (Australia).

Lonza

Lonza headquartered in Basel, Switzerland, founded in 1897. The company enable a healthier world by supporting our healthcare customers on the path to commercialization. The company has various product categories that are Cell Culture, Cell & Gene Therapy, Protein & Vaccine Production, Primary & Stem Cell Culture, Transfection, Drug Discovery, In vitro ADME-Tox Tools, Endotoxin & Pyrogen Testing, Paperless Solutions, and Automated Aseptic Sampling. The deals in various business segments Small Molecules, Biologics, Cell & Gene, and Capsules & Health Ingredients. The company is attaining lucrative growth through several strategic initiatives.

For instance,

  • In April 2019, Lonza has launched a fully automated robotic solution ‘PyroTecPRO Robotic Solution’ for simple, fast, and reliable endotoxin detection. This product launch has helped the company to widen the company’s product portfolio.

The company has presence in North America, South America, Europe, Asia-Pacific, and Middle East Africa. The company also has various subsidiary companies such as Arch Chemicals, Inc. (US), Arch Personal Care Products, L.P. (US), Lonza Biologics Tuas Pte. Ltd (Singapore), Lonza India Private Limited (India), Lonza Japan Ltd (Lonza Japan Kabushiki Kaisha) (Japan).

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. founded in 1962. The company’s headquartered in Massachusetts, U.S. The company is focused in manufacturing scientific instruments, consumables, and chemicals. The company operates in four business segments- Lifesciences, Industrial & Applied Sciences, Speciality Diagnostics, Laboratory products & services. The company is attaining lucrative growth through several strategic initiatives.

  • In April 2021, Thermo Fisher Scientific Inc. entered into a definitive agreement with PPD, Inc. According to the agreement, the company will acquire PPD, Inc. for USD 47.50/share of a total worth of USD 17.4 Billion. The agreement will help the company to develop new competencies and resources.

The company has wide presence in Americas, Europe, Asia-Pacific, Middle East and Africa. The company also has various subsidiary companies such as Patheon (U.S.), Dionex (U.S.), Cole Palmer (U.S.), Affymertrix (U.S.), Applied Biosystems (U.S.), Thermo Trace Limited (Australia), Laboratory Management Systems Inc(Delaware), Jouan Nordics AS (Denmark), among others.